Outcomes Network Graph
Outcomes Flow Chart
Treatment Effectiveness
User reported effectiveness ratings Clonazepam (Klonopin, Rivotril) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Bipolar Disorder | 20% | 44% | 12% | 18% | 6% | 50 |
| Chronic Fatigue Syndrome | 14% | 38% | 14% | 29% | 5% | 152 |
| Insomnia | 24% | 38% | 7% | 18% | 13% | 68 |
Side Effects
User-reported side effects of Clonazepam (Klonopin, Rivotril)
| Side Effect | Percent of Reports Clonazepam (Klonopin, Rivotril) |
|---|---|
| Blurred Vision | 17% |
| Changes in Sex Drive or Ability | 28% |
| Difficulty Thinking or Remembering | 51% |
| Dizziness | 34% |
| Drowsiness | 76% |
| Frequent Urination | 17% |
| Increased Saliva | 6% |
| Muscle or Joint Pain | 13% |
| Problems With Coordination | 32% |
| Unsteadiness | 35% |
Outcomes
Below is the degree of change seen after Clonazepam (Klonopin, Rivotril) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Clonazepam (Klonopin, Rivotril) Info
| Property | Value |
|---|---|
| Variable Name | Clonazepam (Klonopin, Rivotril) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-07 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 22.400781016069 |
| Mean | 0.062521 count |
| Median | 0 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 15 |
| Number of Measurements | 17 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 17 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0.25250243568218 |
| Unit | Count |
| User Variables | 3 |
| Variable Category | Treatments |
| Variable ID | 92949 |
| Variance | 0.069071472120608 |